Mycronic AB (MYCR) AI Stock Analysis

• Market Cap: kr40.26B
• Dividend Yield: 25.84%
• Average Volume (3M): 208.13K
• Price to Earnings (P/E): 22.1
• Beta (1Y): 1.13
• Revenue Growth: 21.51%
• EPS Growth: 35.67%
• Country: SE
• Employees: 2,318
• Sector: Technology
• Sector Strength: 88
• Industry: Industrial - Machinery
• EPS (TTM): 3.17
• Shares Outstanding: 195,833,020
• 10 Day Avg. Volume: 230,853
• 30 Day Avg. Volume: 208,131
• PEG Ratio: 2.55
• Price to Book (P/B): 6.10
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 46.11
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 77 Outperform
• Price Target: kr222.00 ▲(8.19%Upside)

The stock's overall score is driven by strong financial performance, characterized by robust revenue and profit growth and a solid balance sheet. The technical analysis indicates a neutral trend, and the valuation is reasonable, bolstered by a high dividend yield.

Mycronic AB Business Overview & Revenue Model

Company Description

Mycronic AB is a Swedish high-tech company specializing in the development and manufacturing of production equipment for the electronics industry. The company operates in segments such as Pattern Generators and Assembly Solutions, providing advanced solutions for the production of electronic components and microelectronics. Mycronic is renowned for its innovative technology in areas like mask writers for displays and high-precision assembly equipment, catering to a global clientele in the electronics manufacturing sector.

How the Company Makes Money

Mycronic AB generates revenue primarily through the sale of its production equipment and solutions to electronics manufacturers. The company's key revenue streams include the Pattern Generators segment, where it supplies mask writers used in the production of advanced displays, and the Assembly Solutions segment, which provides high-precision assembly equipment for electronic components. Mycronic also earns from service contracts, spare parts, and software upgrades for its equipment. Strategic partnerships with major electronics manufacturers and continuous innovation in technology contribute significantly to its earnings.

Mycronic AB Financial Statement Overview

Summary

Mycronic AB exhibits strong financial health across its income statement, balance sheet, and cash flow. The income statement reflects healthy growth and profitability with a 31.54% increase in revenue and strong margins. The balance sheet is robust with low leverage and high equity, ensuring financial stability. While cash flow is strong, a decline in free cash flow warrants attention.

Income Statement

Mycronic AB shows strong revenue growth with a 31.54% increase from 2023 to TTM. The gross profit margin is robust at 54.0% TTM, indicating effective cost management. Net profit margin improved to 24.2%, suggesting enhanced profitability. EBIT and EBITDA margins are solid at 29.8% and 29.9% respectively, indicating efficient operations. Overall, the income statement reflects healthy growth and profitability.

Balance Sheet

The company maintains a strong balance sheet with a low debt-to-equity ratio of 0.03, demonstrating conservative leverage. Return on equity is impressive at 25.7%, indicating efficient use of equity to generate profits. The equity ratio of 67.1% reflects a solid capital structure and financial stability. The balance sheet suggests low financial risk and strong shareholder value.

Cash Flow

Operating cash flow to net income ratio is healthy at 0.76, showing reliable cash generation from operations. However, free cash flow decreased by 17.8% from 2024 to TTM, primarily due to reduced operating cash flow. Despite this, the free cash flow to net income ratio remains strong at 0.74, indicating good cash conversion. Overall, cash flow performance is robust but shows slight pressure from declining free cash flow.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	7.51B	7.06B	5.71B	5.12B	4.63B	3.88B
Gross Profit	4.05B	3.72B	2.72B	2.29B	2.28B	2.08B
EBITDA	2.24B	2.32B	1.39B	1.11B	1.15B	1.06B
Net Income	1.81B	1.68B	998.00M	741.00M	828.00M	694.00M
Balance Sheet
Total Assets	10.53B	10.41B	8.34B	7.34B	6.14B	5.32B
Cash, Cash Equivalents and Short-Term Investments	2.99B	3.01B	2.14B	1.27B	683.00M	1.30B
Total Debt	214.00M	219.00M	228.00M	270.00M	243.00M	264.00M
Total Liabilities	3.47B	3.84B	3.06B	2.64B	2.14B	1.94B
Stockholders Equity	7.06B	6.53B	5.25B	4.66B	3.96B	3.36B
Cash Flow
Free Cash Flow	1.34B	1.64B	1.41B	712.00M	908.00M	991.00M
Operating Cash Flow	1.38B	1.87B	1.61B	853.00M	998.00M	1.13B
Investing Cash Flow	-616.00M	-500.00M	-195.00M	67.00M	-1.22B	-150.00M
Financing Cash Flow	-554.00M	-552.00M	-447.00M	-382.00M	-437.00M	-288.00M

Mycronic AB Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 205.20
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:MYCR, the sentiment is Positive. The current price of 205.2 is above the 20-day moving average (MA) of 193.11, above the 50-day MA of 193.33, and above the 200-day MA of 201.25, indicating a bullish trend. The MACD of 3.79 indicates Negative momentum. The RSI at 64.40 is Neutral, neither overbought nor oversold. The STOCH value of 92.04 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:MYCR.

Mycronic AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
MYCR	77 Outperform	kr40.26B	22.11	28.32%	25.84%	21.51%	35.67%
ALIG	77 Outperform	€16.16B	23.58	9.04%	1.99%	0.13%	29.88%
ALIG	77 Outperform	€16.16B	23.58	9.04%	1.99%	0.13%	29.88%
AQ	76 Outperform	kr16.69B	25.80	15.07%	8.61%	-3.59%	-1.67%
AQ	76 Outperform	kr16.69B	25.80	15.07%	8.61%	-3.59%	-1.67%
BEIJ.B	73 Outperform	kr79.11B	34.28	10.11%	8.64%	13.64%	-4.83%
BEIJ.B	73 Outperform	kr79.11B	34.28	10.11%	8.64%	13.64%	-4.83%
TROAX	64 Neutral	kr8.75B	25.60	16.33%	27.67%	2.59%	-11.50%
TROAX	64 Neutral	kr8.75B	25.60	16.33%	27.67%	2.59%	-11.50%
FAG	61 Neutral	kr7.78B	26.99	3.84%	3.16%	-5.29%	-44.98%
FAG	61 Neutral	kr7.78B	26.99	3.84%	3.16%	-5.29%	-44.98%
Sector *	59 Neutral	€3.07B	11.74	-8.77%	2.65%	5.08%	-50.65%

Mycronic AB Corporate Events

Mycronic Expands in South Korea with Cowin DST Acquisition

Mycronic’s Pattern Generators division has agreed to acquire Cowin DST, a South Korean company specializing in display panel and photomask repair systems. This acquisition will enhance Mycronic’s product offerings and strengthen its presence in South Korea, a key market for semiconductors and displays, while opening new market opportunities and improving customer solutions.

Mycronic AB to Present Q2 2025 Financial Results

Mycronic AB has announced an upcoming presentation for its Q2 2025 financial results, scheduled for July 11, 2025. The presentation will be led by the company’s President and CEO, Anders Lindqvist, and CFO, Pierre Brorsson, with a webcast available for analysts, investors, and media. This event is significant for stakeholders as it provides insights into the company’s financial health and strategic direction.

Mycronic Expands Semiconductor Capabilities with Surfx Acquisition

Mycronic’s Global Technologies division has acquired Surfx Technologies, a US-based provider of atmospheric plasma solutions for surface treatment in electronics manufacturing. This acquisition enhances Mycronic’s capabilities in semiconductor industry equipment, particularly in 3D semiconductor die stacking, a key technology for AI advancements, and positions Mycronic as a leader in manufacturing equipment for the semiconductor sector.

Mycronic AB Announces Share Split to Boost Liquidity

Mycronic AB has announced a share split, doubling the number of shares from one to two, with the record date set for June 4, 2025. This move, approved at the annual general meeting, aims to enhance share liquidity and accessibility, with trading under a new ISIN code starting June 3, 2025, and no action required from shareholders.

Mycronic Rebrands High Flex Division to PCB Assembly Solutions

Mycronic has rebranded its High Flex division to PCB Assembly Solutions, reflecting its expanded product offerings in advanced production equipment for PCB assemblies. This strategic move aligns with Mycronic’s market focus and long-term growth plans, potentially enhancing its industry positioning and stakeholder engagement.

Mycronic AB Announces Dividend and Strategic Resolutions at AGM

At the Annual General Meeting of Mycronic AB, key resolutions included the approval of a SEK 7.50 per share dividend, re-election of board members, and the introduction of a long-term incentive program for key employees. The meeting also authorized share splits and potential new share issues, reflecting strategic moves to enhance shareholder value and align employee interests with those of shareholders.